Drugs Made In America Acquisition Corp. is a blank check company, which engages in the provision of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The company is headquartered in Fort Lauderdale, Florida. The company went IPO on 2025-01-28. The firm is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The firm intends to focus its search for businesses in the pharmaceutical industry. The firm has neither engaged in any operations nor generated any revenues.
DMAAU stock price ended at $10.55 on 木曜日, after rising 0.00%
On the latest trading day Jan 29, 2026, the stock price of DMAAU rose by 0.00%, climbing from $10.55 to $10.55. During the session, the stock saw a volatility of 0.00%, with prices oscillating between a daily low of $10.55 and a high of $10.55. Notably, trading volume dropped by 322 shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 608 shares were traded, equating to a market value of approximately $353.6M.